Enhanced bone morphogenetic protein-2 performance on hydroxyapatite ceramic surfaces

被引:42
|
作者
Schuessele, A. [1 ]
Mayr, H. [2 ]
Tessmar, J. [1 ]
Goepferich, A. [1 ]
机构
[1] Univ Regensburg, Dept Pharmaceut Technol, D-8400 Regensburg, Germany
[2] Friedrich Baur Res Inst Biomat, Bayreuth, Germany
关键词
surface modification; hydroxyapatite; BMP-2; biomimetic material; ceramics; 3-DIMENSIONAL CELL-CULTURE; GROWTH-FACTOR BETA(1); IN-VIVO; OSTEOBLASTIC DIFFERENTIATION; TITANIUM SURFACES; TISSUE FORMATION; IMPLANTS; BISPHOSPHONATES; BMP-2; RATS;
D O I
10.1002/jbm.a.31745
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The immobilization of biomolecules on biomaterial surfaces allows for the control of their localization and retention. In numerous studies, proteins have been simply adsorbed to enhance the biological performance of various materials in vivo. We investigated the potential of surface modification techniques on hydroxyapatite (HA) ceramic discs in an in vitro approach. A novel method for protein immobilization was evaluated using the aminobisphosphonates pamidronate and alendronate, which are strong Ca chelating agents, and was compared with the established silanization technique. Lysozyme and bone morphogenetic protein-2 (BMP-2) were used to assess the suitability of the two surface modification methods with regard to the enzymatic activity of lysozyme and to the capacity of BMP-2 to stimulate the osteoblastic differentiation of C2C12 mouse myoblasts. After immobilization, a 2.5-fold increase in enzymatic activity of lysozyme was observed compared with the control. The alkaline phosphatase activity per cell stimulated by immobilized BMP-2 was 2.5-fold higher [9 x 10(-6) I.U.] than the growth factor on unmodified surfaces [2-4 x 10(-6) I.U.]. With regard to the increase in protein activity, both procedures lead to equivalent results. Thus, the bisphosphonate-based surface modification represents a safe and easy alternative for the attachment of proteins to HA surfaces. (C) 2008 Wiley Periodicals, Inc. J Biomed Mater Res 90A: 959-971, 2009
引用
收藏
页码:959 / 971
页数:13
相关论文
共 50 条
  • [41] Enhanced osteogenic activity of bone morphogenetic protein-2 by 2-O-desulfated heparin
    Ratanavaraporn, Juthamas
    Tabata, Yasuhiko
    ACTA BIOMATERIALIA, 2012, 8 (01) : 173 - 182
  • [42] Adverse events and bone morphogenetic protein-2 Response
    Dmitriev, Anton E.
    Lehman, Ronald A., Jr.
    Symes, Aviva J.
    SPINE JOURNAL, 2011, 11 (08): : 802 - 803
  • [43] Regulation of microRNA expression by bone morphogenetic protein-2
    Sato, Mari M.
    Yawaka, Yasutaka
    Tamura, Masato
    INTERFACE ORAL HEALTH SCIENCE 2009, 2010, : 158 - 160
  • [44] Sinus Floor Augmentation Using Recombinant Human Bone Morphogenetic Protein-2 With Hydroxyapatite: Volume Assessment
    Nam, Jung Woo
    Chee, Young Deok
    Park, Young Bum
    JOURNAL OF CRANIOFACIAL SURGERY, 2020, 31 (04) : 912 - 915
  • [45] Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2
    Zebboudj, AF
    Imura, M
    Boström, K
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (06) : 4388 - 4394
  • [46] Recombinant human bone morphogenetic protein-2 potentiates the in vivo osteogenic ability of marrow/hydroxyapatite composites
    Noshi, T
    Yoshikawa, T
    Dohi, Y
    Ikeuchi, M
    Horiuchi, K
    Ichijima, K
    Sugimura, M
    Yonemasu, K
    Ohgushi, H
    ARTIFICIAL ORGANS, 2001, 25 (03) : 201 - 208
  • [47] Hollow hydroxyapatite microspheres: A novel bioactive and osteoconductive carrier for controlled release of bone morphogenetic protein-2 in bone regeneration
    Xiao, Wei
    Fu, Hailuo
    Rahaman, Mohamed N.
    Liu, Yonxing
    Bal, B. Sonny
    ACTA BIOMATERIALIA, 2013, 9 (09) : 8374 - 8383
  • [48] Incorporation of Calcium Sulfate Dihydrate into Hydroxyapatite Microspheres To Improve the Release of Bone Morphogenetic Protein-2 and Accelerate Bone Regeneration
    Baek, Jaeuk
    Lee, Hyun
    Jang, Tae-Sik
    Song, Juha
    Kim, Hyoun-Ee
    Jung, Hyun-Do
    ACS BIOMATERIALS SCIENCE & ENGINEERING, 2018, 4 (03): : 846 - 856
  • [49] Enhanced vertical alveolar bone augmentation by recombinant human bone morphogenetic protein-2 with a carrier in rats
    Shimazu, C.
    Hara, T.
    Kinuta, Y.
    Moriya, K.
    Maruo, Y.
    Hanada, S.
    Minagi, S.
    JOURNAL OF ORAL REHABILITATION, 2006, 33 (08) : 609 - 618
  • [50] Recombinant human bone morphogenetic protein-2 and collagen for bone regeneration
    Hollinger, JO
    Schmitt, JM
    Buck, DC
    Shannon, R
    Joh, SP
    Zegzula, HD
    Wozney, J
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH, 1998, 43 (04): : 356 - 364